Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honglin Jin

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Nature Nanotechnology|April 16, 2026
Enhancing antitumour nanovaccine efficacy via integrated cholesterol modulation in situZihan Deng, Lisen Lu, Tianbing Xu, et al.
Nanoscale|July 7, 2020
Relieving immunosuppression during long-term anti-angiogenesis therapy using photodynamic therapy and oxygen deliveryQianyuan He, Zhanjie Zhang, Haojie Liu, et al.
Theranostics|August 18, 2020
USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung CancerXiaomeng Dai, Lisen Lu, Suke Deng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 18, 2026
Pyroptosis-Inducing Engineered Microparticles for Cancer ImmunotherapyTianli Hao, Zihan Deng, Yufei Liu, et al.
Nanoscale|January 3, 2025
Correction: Relieving immunosuppression during long-term anti-angiogenesis therapy using photodynamic therapy and oxygen deliveryQianyuan He, Zhanjie Zhang, Haojie Liu, et al.
Aging|January 8, 2020
Downregulation of ABI2 expression by EBV-miR-BART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN/SLUG signalingJing Huang, You Qin, Chensu Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 26, 2023
Engineered Microparticles for Treatment of Murine Brain Metastasis by Reprograming Tumor Microenvironment and Inhibiting MAPK PathwayLisen Lu, Huaduan Zi, Jie Zhou, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 4, 2009
HDL-mimicking peptide-lipid nanoparticles with improved tumor targetingZhihong Zhang, Juan Chen, Lili Ding, et al.
Theranostics|March 21, 2020
Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogelXiaomeng Dai, Jingshu Meng, Suke Deng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 3, 2023
Ferroptosis-Enhanced Immunotherapy with an Injectable Dextran-Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular CarcinomaJingshu Meng, Xiao Yang, Jing Huang, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Nature Nanotechnology|April 16, 2026
Enhancing antitumour nanovaccine efficacy via integrated cholesterol modulation in situZihan Deng, Lisen Lu, Tianbing Xu, et al.
Nanoscale|July 7, 2020
Relieving immunosuppression during long-term anti-angiogenesis therapy using photodynamic therapy and oxygen deliveryQianyuan He, Zhanjie Zhang, Haojie Liu, et al.
Theranostics|August 18, 2020
USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung CancerXiaomeng Dai, Lisen Lu, Suke Deng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 18, 2026
Pyroptosis-Inducing Engineered Microparticles for Cancer ImmunotherapyTianli Hao, Zihan Deng, Yufei Liu, et al.
Nanoscale|January 3, 2025
Correction: Relieving immunosuppression during long-term anti-angiogenesis therapy using photodynamic therapy and oxygen deliveryQianyuan He, Zhanjie Zhang, Haojie Liu, et al.
Aging|January 8, 2020
Downregulation of ABI2 expression by EBV-miR-BART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN/SLUG signalingJing Huang, You Qin, Chensu Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 26, 2023
Engineered Microparticles for Treatment of Murine Brain Metastasis by Reprograming Tumor Microenvironment and Inhibiting MAPK PathwayLisen Lu, Huaduan Zi, Jie Zhou, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 4, 2009
HDL-mimicking peptide-lipid nanoparticles with improved tumor targetingZhihong Zhang, Juan Chen, Lili Ding, et al.
Theranostics|March 21, 2020
Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogelXiaomeng Dai, Jingshu Meng, Suke Deng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 3, 2023
Ferroptosis-Enhanced Immunotherapy with an Injectable Dextran-Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular CarcinomaJingshu Meng, Xiao Yang, Jing Huang, et al.
Pageof 8